Emergent BioSolutions Inc. Common Stock (EBS) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
EBS has 1 Form 4 insider filing recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001367644 (2026-04-11) ↗